Global Irbesartan Tablets Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Irbesartan Tablets Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Irbesartan is an oral medication that is used to treat high blood pressure (hypertension) and diabetic nephropathy or kidney disease. It belongs to a class of drugs called angiotensin receptor blockers (ARBs).
Irbesartan Tablets report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Irbesartan Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Irbesartan Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Irbesartan Tablets key manufacturers include Teva, Sanofi, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Zhuhai Rundu Pharmaceutica and Verdant Life Sciences, etc. Teva, Sanofi, Taj Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Irbesartan Tablets can be divided into 75 mg Tablets, 150 mg Tablets and 300 mg Tablets,, etc. 75 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Irbesartan Tablets is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Irbesartan Tablets industry development. In 2022, global % sales of Irbesartan Tablets went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Irbesartan Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva
Sanofi
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Zhuhai Rundu Pharmaceutica
Verdant Life Sciences
Segment by Type
75 mg Tablets
150 mg Tablets
300 mg Tablets
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Irbesartan Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Irbesartan Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Irbesartan Tablets industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Irbesartan Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Irbesartan Tablets introduction, etc. Irbesartan Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Irbesartan Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Irbesartan Tablets report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Irbesartan Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Irbesartan Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Irbesartan Tablets key manufacturers include Teva, Sanofi, Taj Pharmaceuticals, Apotex, Jiangsu Hengrui Medicine, Zhuhai Rundu Pharmaceutica and Verdant Life Sciences, etc. Teva, Sanofi, Taj Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Irbesartan Tablets can be divided into 75 mg Tablets, 150 mg Tablets and 300 mg Tablets,, etc. 75 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Irbesartan Tablets is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Irbesartan Tablets industry development. In 2022, global % sales of Irbesartan Tablets went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Irbesartan Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva
Sanofi
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Zhuhai Rundu Pharmaceutica
Verdant Life Sciences
Segment by Type
75 mg Tablets
150 mg Tablets
300 mg Tablets
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Irbesartan Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Irbesartan Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Irbesartan Tablets industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Irbesartan Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Irbesartan Tablets introduction, etc. Irbesartan Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Irbesartan Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.